江苏普莱医药递表港交所 中信证券任独家保荐人

Core Viewpoint - Jiangsu Pulaim Pharmaceutical Co., Ltd. has officially submitted its listing application to the Hong Kong Stock Exchange on February 13, with CITIC Securities acting as the sole sponsor [1] Company Summary - Pulaim Pharmaceutical is headquartered in Jiangsu and aims to complete its listing within the year, potentially becoming another mainland biopharmaceutical company to go public in Hong Kong [1]